Login Register Cart 0
Generic placeholder image

Current Traditional Medicine

Editor-in-Chief

ISSN (Print): 2215-0838
ISSN (Online): 2215-0846

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Screening of Natural Antivirals Against the COVID-19 Pandemic- A Compilation of Updates

Author(s): Baishakhi De, Tridib Kumar Goswami* and Vijaya G.S. Raghavan

Volume 9, Issue 5, 2023

Published on: 20 October, 2022

Article ID: e020622205565 Pages: 12

DOI: 10.2174/2215083808666220602115932

Price: $65

Abstract

Coronavirus disease 2019 (COVID-19), named by WHO, is a real public health disaster of the third millennium. This highly contagious viral disease has infected the world population and is now a global pandemic. This acute respiratory distress syndrome (ARDS) has severe complications like pneumonitis, respiratory failure, shock, multiorgan failure, and death. Well-defined FDAapproved synthetic is not yet available. Case management strategies like lockdown, use of masks and sanitizers, social distancing, and repurposing of antiviral drugs were initially undertaken to cope with this pandemic. Different broad-spectrum antiviral drugs are being repurposed as one of the treatment modalities. The global vaccination programme with the newly launched COVID-19 vaccines, Covishield, covaxin, sputnik V, etc., is an ongoing process. Simultaneously, significant research is being carried out in search of natural antivirals and evaluating the potency of food bioactives to aid naturistic protection against the coronavirus. This mini-review has compiled the latest updates on the screening and evidence-based mechanistic evaluation of phytochemicals and food bioactives as non-pharmacological adjuvant aid in COVID pandemics.

Keywords: Coronavirus, pandemic, natural antivirals, phytochemicals, food bioactives, non-pharmacologic.

[1]
Harapan H, Itoh N, Yufika A, et al. Coronavirus disease 2019 (COVID-19): A literature review. J Infect Public Health 2020; 13(5): 667-73.
[http://dx.doi.org/10.1016/j.jiph.2020.03.019] [PMID: 32340833]
[2]
Meo SA, Al-Khlaiwi T, Usmani AM, Meo AS, Klonoff DC, Hoang TD. Biological and epidemiological trends in the prevalence and mortality due to outbreaks of novel coronavirus COVID-19. J King Saud Univ Sci 2020; 32(4): 2495-9.
[http://dx.doi.org/10.1016/j.jksus.2020.04.004] [PMID: 32292261]
[3]
Kumar D, Malviya R, Sharma KP. Corona virus: A review of COVID-19. EJMO 2020; 4(1): 8-25.
[http://dx.doi.org/10.14744/ejmo.2020.51418]
[4]
Pastick KA, Okafor EC, Wang F, et al. Review: Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19). Open Forum Infect Dis 2020; 7(4): a130.
[http://dx.doi.org/10.1093/ofid/ofaa130] [PMID: 32363212]
[5]
Mishra A, Patra S, Shukla SK, et al. Current scenario of coronavirus pandemic. Adv Mater Lett 2020; 11(4): 1-8.
[http://dx.doi.org/10.5185/amlett.2020.041494]
[6]
Kaul D. An overview of coronaviruses including the SARS-2 coronavirus - Molecular biology, epidemiology and clinical implications. Curr Med Res Pract 2020; 10(2): 54-64.
[http://dx.doi.org/10.1016/j.cmrp.2020.04.001] [PMID: 32363221]
[7]
Sharma P, Veer K. Action and problems related to the COVID-19 outbreak in India. Infect Control Hosp Epidemiol 2020; 41(12): 1478-9.
[http://dx.doi.org/10.1017/ice.2020.186] [PMID: 32362293]
[8]
Singh BP. Forecasting novel corona positive cases in India using truncated information: A mathematical approach. MedRxiv 2020.
[http://dx.doi.org/10.1101/2020.04.29.20085175]
[9]
Ahmad T. Scenario of the corona virus (COVID-19) in India. SSRN Electron J 2020. Available from:
[http://dx.doi.org/10.2139/ssrn.3568847]
[10]
Kachroo V. Novel corona virus (COVID-19) in India: Current scenario. IJRR 2020; 7(3): 435-47.
[11]
Krishnakumar B, Rana S. COVID-19 in INDIA: Strategies to combat from combination threat of life and livelihood. J Microbiol Immunol Infect 2020; 53(3): 389-91.
[http://dx.doi.org/10.1016/j.jmii.2020.03.024] [PMID: 32253143]
[12]
Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol 2020; 38(1): 1-9.
[http://dx.doi.org/10.12932/AP-200220-0772] [PMID: 32105090]
[13]
Li G, Fan Y, Lai Y, et al. Coronavirus infections and immune responses. J Med Virol 2020; 92(4): 424-32.
[http://dx.doi.org/10.1002/jmv.25685] [PMID: 31981224]
[14]
Wang L, Wang Y, Ye D, Liu Q. Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. Int J Antimicrob Agents 2020; 55(6): 105948.
[http://dx.doi.org/10.1016/j.ijantimicag.2020.105948] [PMID: 32201353]
[15]
Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A review. JAMA 2020; 323(18): 1824-36.
[http://dx.doi.org/10.1001/jama.2020.6019] [PMID: 32282022]
[16]
Arnold C. Taking down COVID-19. New Sci 2020; 245(3276): 44-7.
[http://dx.doi.org/10.1016/S0262-4079(20)30692-8] [PMID: 32372796]
[17]
Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). Treasure Island, FL: StatPearls Publishing 2022.
[18]
Vellingiria B, Jayaramayya K, Iyer M, et al. Subramaniam COVID-19: A promising cure for the global panic. Sci Total Environ 2020; 725: 138277.
[http://dx.doi.org/10.1016/j.scitotenv.2020.138277]
[19]
Pang J, Wang MX, Han Ang IY, et al. Potential rapid diagnostics, vaccine and therapeutics for 2019 novel corona virus (2019-nCoV): A systematic review. J Clin Med 2020; 9(3): 1-33.
[http://dx.doi.org/10.3390/jcm9030623] [PMID: 32110875]
[20]
Liang T. Handbook of COVID-19 Prevention and Treatment. 2020.
[21]
Kundu D, Selvaraj C, Singh SK, Dubey VK. Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target. J Biomol Struct Dyn 2021; 39(9): 3428-34.
[http://dx.doi.org/10.1080/07391102.2020.1763202] [PMID: 32362243]
[22]
Jayawardena R, Sooriyaarachchi P, Chourdakis M, Jeewandara C, Ranasinghe P. Enhancing immunity in viral infections, with special emphasis on COVID-19: A review. Diabetes Metab Syndr 2020; 14(4): 367-82.
[http://dx.doi.org/10.1016/j.dsx.2020.04.015] [PMID: 32334392]
[23]
Khaled MB, Benajiba N. The role of nutrition in strengthening immune system against newly emerging viral diseases: Case of SARS-CoV-2. NAJFNR 2020; 04(7): 240-4.
[http://dx.doi.org/10.51745/najfnr.4.7.240-244]
[24]
Lin LT, Hsu WC, Lin CC. Antiviral natural products and herbal medicines. J Tradit Complement Med 2014; 4(1): 24-35.
[http://dx.doi.org/10.4103/2225-4110.124335] [PMID: 24872930]
[25]
Park JY, Yuk HJ, Ryu HW, et al. Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors. J Enzyme Inhib Med Chem 2017; 32(1): 504-15.
[http://dx.doi.org/10.1080/14756366.2016.1265519] [PMID: 28112000]
[26]
Tillu G, Chaturvedi S, Chopra A, Patwardhan B. Public health approach of Ayurveda and Yoga for COVID-19 prophylaxis. J Altern Complement Med 2020; 26(5): 360-4.
[http://dx.doi.org/10.1089/acm.2020.0129] [PMID: 32310670]
[27]
Nikhat S, Fazil M. Overview of COVID-19; its prevention and management in the light of Unani medicine. Sci Total Environ 2020; 728: 138859.
[http://dx.doi.org/10.1016/j.scitotenv.2020.138859] [PMID: 32334163]
[28]
Manzano-Santana PI, Peñarreta Tivillin JP, Chóez-Guaranda IA, Lucas ADB, Orellana-Manzano AK, Rastrelli L. Potential bioactive compounds of medicinal plants against new corona virus (SARS-CoV-2): A review. Bionatura 2021; 6(1): 1653-8.
[http://dx.doi.org/10.21931/RB/2021.06.01.30]
[29]
Tallei TE, Tumilaar SG, Niode NJ, et al. Potential of plant bioactive compounds as SARS-CoV-2 main protease (Mpro) and spike (S) glycoprotein inhibitors: A molecular docking study. Scientifica (Cairo) 2020; 2020: 6307457.
[http://dx.doi.org/10.1155/2020/6307457] [PMID: 33425427]
[30]
Kadioglu O, Saeed M, Greten HJ, Efferth T. Identification of novel compounds against three targets of SARS-CoV-2 coronavirus by combined virtual screening and supervised machine learning. Comput Biol Med 2021; 133: 104359.
[http://dx.doi.org/10.1016/j.compbiomed.2021.104359] [PMID: 33845270]
[31]
Sharma J, Kumar BV, Singh R, Rajendran V, Purohit R, Kumar S. An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2. Food Chem 2021; 346: 128933.
[http://dx.doi.org/10.1016/j.foodchem.2020.128933] [PMID: 33418408]
[32]
Johar P, Choudhary P. Analysis of bioactive compounds for the management of COVID-19. Int J Biotech & Bioeng 2021; 7: 1-8.
[33]
Xian Y, Zhang J, Bian Z, et al. Bioactive natural compounds against human coronaviruses: A review and perspective. Acta Pharm Sin B 2020; 10(7): 1163-74.
[http://dx.doi.org/10.1016/j.apsb.2020.06.002] [PMID: 32834947]
[34]
Singh YD, Jena B, Ningthoujam R, et al. Potential bioactive molecules from natural products to combat against coronavirus. Adv Trad Med 2020; 1-12.
[http://dx.doi.org/10.1007/s13596-020-00496-w]
[35]
da Silva Antonio A, Wiedemann LSM, Veiga-Junior VF. Natural products’ role against COVID-19. RSC Adv 2020; 10(39): 23379-93.
[http://dx.doi.org/10.1039/D0RA03774E]
[36]
Kandeil A, Mostafa A, Kutkat O, et al. Bioactive polyphenolic compounds showing strong antiviral activities against severe acute respiratory syndrome coronavirus 2. Pathogens 2021; 10(6): 758.
[http://dx.doi.org/10.3390/pathogens10060758] [PMID: 34203977]
[37]
Hamimed S, Jebli N, Hamimed R, Landoulsi A, Chatti A. Phytochemicals candidates as promising preventives and/or curatives for COVID-19 Infection: A brief review. Insights Biol Med 2021; 5(1): 1-6.
[http://dx.doi.org/10.29328/journal.ibm.1001019]
[38]
Ashraf Z, Gani A, Shah A, et al. Bioactive compounds from plant sources as natural antivirals in combating RNA based viruses including COVID-19. J Food Sci Nutr 2021; 7: 085.
[39]
Sharanya CS, Sabu A, Haridas M. Potent phytochemicals against COVID-19 infection from phyto-materials used as antivirals in complementary medicines: A review. Future J Pharm Sci 2021; 7(1): 113.
[http://dx.doi.org/10.1186/s43094-021-00259-7] [PMID: 34095323]
[40]
Weng JK. Plant solutions for the COVID-19 pandemic and beyond: Historical reflections and future perspectives. Mol Plant 2020; 13(6): 803-7.
[http://dx.doi.org/10.1016/j.molp.2020.05.014] [PMID: 32442649]
[41]
Remali J, Aizat WM. A review on plant bioactive compounds and their modes of action against coronavirus infection. Front Pharmacol 2021; 11: 589044.
[http://dx.doi.org/10.3389/fphar.2020.589044] [PMID: 33519449]
[42]
Chojnacka K, Witek-Krowiak A, Skrzypczak D, Mikula K, Młynarz P. Phytochemicals containing biologically active polyphenols as an effective agent against COVID-19-inducing coronavirus. J Funct Foods 2020; 73: 104146.
[http://dx.doi.org/10.1016/j.jff.2020.104146] [PMID: 32834835]
[43]
Khazdair MR, Ghafari S, Sadeghi M. Possible therapeutic effects of Nigella sativa and its thymoquinone on COVID-19. Pharm Biol 2021; 59(1): 696-703.
[http://dx.doi.org/10.1080/13880209.2021.1931353] [PMID: 34110959]
[44]
Rahman MT. Potential benefits of combination of Nigella sativa and Zn supplements to treat COVID-19. J Herb Med 2020; 23: 100382.
[http://dx.doi.org/10.1016/j.hermed.2020.100382] [PMID: 32834942]
[45]
Sommer AP, Försterling HD, Sommer KE. Tutankhamun’s antimalarial drug for COVID-19. Drug Res (Stuttg) 2021; 71(1): 4-9.
[http://dx.doi.org/10.1055/a-1274-1264] [PMID: 33128226]
[46]
Khan MA, Younus H. Potential implications of black seed and its principal constituent Thymoquinone in the treatment of COVID-19 patients. Curr Pharm Biotechnol 2021; 22(10): 1315-24.
[http://dx.doi.org/10.2174/1389201021999201110205048] [PMID: 33176642]
[47]
Ahmad A, Rehman MU, Ahmad P, Alkharfy KM. COVID-19 and thymoquinone: Connecting the dots. Phytother Res 2020; 34(11): 2786-9.
[http://dx.doi.org/10.1002/ptr.6793] [PMID: 32588453]
[48]
Xu H, Liu B, Xiao Z, et al. Computational and experimental studies reveal that thymoquinone blocks the entry of coronaviruses into in vitro cells. Infect Dis Ther 2021; 10(1): 483-94.
[http://dx.doi.org/10.1007/s40121-021-00400-2] [PMID: 33532909]
[49]
Badary OA, Hamza MS, Tikamdas R. Thymoquinone: A promising natural compound with potential benefits for COVID-19 prevention and cure. Drug Des Devel Ther 2021; 15: 1819-33.
[http://dx.doi.org/10.2147/DDDT.S308863] [PMID: 33976534]
[50]
Sommer AP, Försterling HD, Naber KG. Thymoquinone: Shield and sword against SARS-CoV-2. Precis Nanomed 2020; 3(3): 541-8.
[51]
Ferid A, Mohammed A, Khalivulla SI, Korivi M, Abdul Razab MKA. Plant cell and callus cultures as an alternative source of bioactive compounds with therapeutic potential against coronavirus disease (COVID-19). IOP Conf Ser Earth Environ Sci 2020; 596(1): 012099.
[http://dx.doi.org/10.1088/1755-1315/596/1/012099]
[52]
Galanakis CM, Aldawoud TMS, Rizou M, Rowan NJ, Ibrahim SA. Food ingredients and active compounds against the coronavirus disease (COVID-19) pandemic: A comprehensive review. Foods 2020; 9(11): 1701.
[http://dx.doi.org/10.3390/foods9111701] [PMID: 33233560]
[53]
Alam J, Hussain T, Pati S. Bio-active compounds (curcumin, allicin and gingerol) of common spices used in Indian and South-East Asian countries might protect against COVID-19 infection: A short review. European J Med Plants 2020; 31(20): 65-78.
[http://dx.doi.org/10.9734/ejmp/2020/v31i2030363]
[54]
Pendyala B, Patras A. In silico screening of food bioactive compounds to predict potential inhibitors of COVID-19 main protease (Mpro) and RNA dependent RNA polymerase (RdRp). ChemRxiv Cambridge Open Engage 2020.
[http://dx.doi.org/10.26434/chemrxiv.12051927.v2]
[55]
Elmahallawy EK, Mohamed Y, Abdo W, El-Gohary FA, Ahmed AAS, Yanai T. New insights into potential benefits of bioactive compounds of bee products on COVID-19: A review and assessment of recent research. Front Mol Biosci 2021; 7: 618318.
[http://dx.doi.org/10.3389/fmolb.2020.618318] [PMID: 33628764]
[56]
Bhatt A, Arora P, Prajapati SK. Can algal derived bioactive metabolites serve as potential therapeutics for the treatment of SARS-CoV-2 like viral infection? Front Microbiol 2020; 11: 596374.
[http://dx.doi.org/10.3389/fmicb.2020.596374] [PMID: 33262750]
[57]
Alam M. Therapeutic potential of marine bioactive compounds against SARS-CoV2 infection. CPQ Medicine 2020; 11(1): 1-18.
[58]
Zaporozhets TS, Besednova NN. Biologically active compounds from marine organisms in the strategies for combating coronaviruses. AIMS Microbiol 2020; 6(4): 470-94.
[http://dx.doi.org/10.3934/microbiol.2020028] [PMID: 33364539]
[59]
Singh S, Dwivedi V, Sanyal D, Dasgupta S. Therapeutic and nutritional potential of spirulina in combating COVID-19 infection. AIJR Preprints 2020.
[http://dx.doi.org/10.21467/preprints.49]
[60]
Sengupta PS. Use of Piper Betel to combat COVID-19. Available from: https://prepare.org.in/preprint/index.php/preprint/article/view/92 (Accessed on 2021 Nov.20).
[61]
Zambrano-Monserrate MA, Ruano MA, Sanchez-Alcalde L. Indirect effects of COVID-19 on the environment. Sci Total Environ 2020; 728: 138813.
[http://dx.doi.org/10.1016/j.scitotenv.2020.138813] [PMID: 32334159]

Rights & Permissions Print Cite
Article Metrics
18
3
© 2024 Bentham Science Publishers | Privacy Policy